These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 19207972)

  • 1. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis B therapy on the long-term outcome of liver disease.
    Liaw YF
    Liver Int; 2011 Jan; 31 Suppl 1():117-21. PubMed ID: 21205148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress and new trends in the treatment of hepatitis B.
    Alberti A; Brunetto MR; Colombo M; Craxì A
    J Med Virol; 2002 Jul; 67(3):458-62. PubMed ID: 12116046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
    Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
    Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of interferon alpha therapy on hepatitis B viral replication in patients with chronic hepatitis B: a meta-analysis.
    Yang YF; Zhao W; Xia HM; Zhong YD; Huang P; Wen J
    Antiviral Res; 2010 Feb; 85(2):361-5. PubMed ID: 19900483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic hepatitis B virus infection: a new era of disease control.
    Farrell GC; Teoh NC
    Intern Med J; 2006 Feb; 36(2):100-13. PubMed ID: 16472264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B in children: complexities in management.
    Kerkar N
    Pediatr Transplant; 2005 Oct; 9(5):685-91. PubMed ID: 16176431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does chemotherapy prevent HBV-related hepatocellular carcinoma? Pros.
    Liaw YF
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S293-7. PubMed ID: 20547317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.
    Chen JY; Wang LW; Sun XM; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):393-7. PubMed ID: 16109523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatitis B.
    Wai CT; Lok AS
    J Gastroenterol; 2002; 37(10):771-8. PubMed ID: 12424559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and prognosis of hepatitis B.
    Fattovich G
    Semin Liver Dis; 2003 Feb; 23(1):47-58. PubMed ID: 12616450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
    Moucari R; Marcellin P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S119-25. PubMed ID: 21095515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of therapy on the outcome of chronic hepatitis B.
    Liaw YF
    Liver Int; 2013 Feb; 33 Suppl 1():111-5. PubMed ID: 23286854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of chronic hepatitis B: an update.
    Morgan M; Park W; Keeffe EB
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):25-41. PubMed ID: 17415343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection.
    Seo Y; Yoon S; Hamano K; Nakaji M; Yano Y; Katayama M; Ninomiya T; Hayashi Y; Kasuga M
    Int J Mol Med; 2004 Jan; 13(1):75-9. PubMed ID: 14654974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.
    Lin SM; Yu ML; Lee CM; Chien RN; Sheen IS; Chu CM; Liaw YF
    J Hepatol; 2007 Jan; 46(1):45-52. PubMed ID: 17107734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.